Supplementation with coconut oil promoted significant differences in the caloric intake of macronutrients, even increasing the energy density of the diet. The CO group consumed less calories from protein (p<0.01) and carbohydrates (p<0.01) and more calories from fat (p<0.01), compared to the control group (Table 2).
Studies with high-fat diets (
Gomes Natal et al., 2016;
Martínez et al., 2018) showed different results, causing an increase in caloric intake. On the other hand, the inclusion of coconut oil in rodent diets has led to a change in energy consumption
(Amaral et al., 2016). Therefore, the results presented here may indicate that the MCTs present in the VCO may be related to greater satiety.
The satiety process is characterized by an inhibition of hunger after a meal, which reduces the amount of calories ingested
(Maher et al., 2020). MCTs are known to produce a rapid feeling of satiety, which may explain similar results of energy intake between the Control and CO groups. MCTs are quickly absorbed through the portal vein and become a ready source of energy supply in the liver. This mechanism contributes to increase satiety and energy expenditure (
Maher and Clegg, 2020;
Maher et al., 2020).
Diets with high levels of SFA’s can promote the accumulation of fat
(Macri et al., 2012; López-Espinoza et al., 2014; Gomes
Natal et al., 2016; Kolahdouzi et al., 2019). The CO group showed a greater accumulation of abdominal fat (p<0.01) compared to the control group, showing that the addition of VCO in the diet led to the development of obesity. Thus, even with the presence of MCTs in their composition and an energy intake close to that of the Control group, CO animals obtained an increase in fat mass
(David et al., 2019). In addition, the strong correlation (r
2 = 0.53; p<0.01) between fat energy intake (not total energy intake) and the accumulation of adipose tissue (Fig 1) confirms that fat intake during a subchronic period increased the accumulation of adipose tissue.
High-fat diets can be precursors of bone metabolism and result in low bone mass and low bone quality
(Macri et al., 2012). In the present study, shorter femur length (p<0.05) was observed in the CO group compared to the control group
(Bielohuby et al., 2010) (Table 3).
Two mechanisms are proposed for this bone dysfunction observed in animals with an SFA-rich diet. First, high-fat diets can lead to a decrease in growth hormone (GH) and insulin-like growth factor (IGF-1) in the bloodstream. The GH/IGF system potently stimulates bone growth, activating the osteoblast differentiation program
(Bielohuby et al., 2010). Second, leptin has been suggested to control bone resorption that is thought to regulate osteoclast differentiation. Although the levels of these hormones (GH, IGF-1 and leptin) were not evaluated in this study, the failure to demonstrate a correlation between adipose tissue (the organ that secretes leptin) and the length of the femur leads to the hypothesis that the high energy consumption of fat might have influenced GH/IGF-1 levels
(Bielohuby et al., 2010). Also, a negative correlation (r
2 = 0.51; p<0.05) was reported between the length of the femur and fatty caloric intake (Fig 2).
The diet added with VCO decreased the total cholesterol levels of the animals. The CO group had lower levels (p<0.01) compared to the control group (Fig 3). This decrease may be due to the presence of MCTs, by increasing the excretion of bile acids in the feces
(Li et al., 2018). In particular, the decrease in LDL-c levels reduces the risk of atherosclerosis
(Escobar et al., 2019; Singh et al., 2019). Therefore, even with the increase in fat mass, the animals in the CO group had lower levels of total cholesterol, which was a beneficial effect of adding VCO to the diet.
The CO group had higher adrenal weight (p<0.001) than the control group (Table 3). There are evidence that high-fat diets can promote hypertrophy of the adrenal glands
(Hryhorczuk et al., 2017) and increase the release of corticosterone
(Sasaki et al., 2013). Corticosterone is a hormone that plays an important role in regulating anxiety
(Sasaki et al., 2013). Here, an increase in anxiety was demonstrated in the CO group, which obtained a low percentage of open arm entries (16,60%), when compared to the control group (33,33%) (Table 4). Therefore, the assumption raised is that the high composition of the SFA may have led to hyperactivity of the hypothalamic-pituitary-adrenal axis and anxiety.
In summary, the present study found few beneficial effects from the sub-chronic use of VCO. Although the animals in the CO group obtained a similar energy intake and decreased the levels of total cholesterol, the development of obesity, anxiogenesis and impaired bone growth were observed. The increase in satiety and the reduction in total cholesterol seem to be related to the presence of MCT’s in the constitution of the VCO. However, due to its high concentration of SFA and also the chronicity of the diet, accumulation of fat mass, anxiogenesis and impaired bone formation were observed. These results indicate that the consumption of VCO in large quantities for long periods should be questioned.